ArticleBiomolecules2022

Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress.

Sidneia Sousa Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.